Login / Signup

Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome.

Xianmei GouLin QinDi WuJian XieYanliu LuQianru ZhangYuqi He
Published in: Molecules (Basel, Switzerland) (2023)
Bile acids are acknowledged as signaling molecules involved in metabolic syndrome. The Takeda G protein-coupled receptor 5 (TGR5) functions as a significant bile acid receptor. The accumulated evidence suggests that TGR5 involves lipid homeostasis, glucose metabolism, and inflammation regulation. In line with this, recent preclinical studies also demonstrate that TGR5 plays a significant role in the generation and progression of metabolic syndrome, encompassing type 2 diabetes mellitus, obesity, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD). In this review, we discuss the role of TGR5 in metabolic syndrome, illustrating the underlying mechanisms and therapeutic targets.
Keyphrases
  • metabolic syndrome
  • insulin resistance
  • uric acid
  • cardiovascular risk factors
  • oxidative stress
  • cardiovascular disease
  • adipose tissue
  • body mass index
  • cell therapy
  • glycemic control
  • weight gain
  • binding protein